Autolus Therapeutics plc - American Depositary Shares (AUTL) SEC filings
AUTL SEC filings moved a median of -0.54% by the close. AUTL SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the AUTL overview →
78 measured AUTL SEC filing events.
Where these AUTL SEC filings landedvs 76 measured AUTL SEC filing reactions
| Middle 50% of AUTL SEC filing reactions | -7.05% to +2.19% |
|---|---|
| Median reaction (to close) | -0.54% |
| Measured reactions | 76 |
Point-in-time · zero look-ahead
Half of the 76 AUTL SEC filing events with a measured close landed between -7.05% and +2.19%; 42% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form EFFECT Autolus Therapeutics | SEC filing · Form EFFECT | -0.73% | -4.41% | |
| Form DEL AM Autolus Therapeutics | SEC filing · Form DEL | -0.52% | -3.11% | |
| Form S-3 Autolus Therapeutics | SEC filing · Form S-3 | +0.27% | +4.30% | |
| Form 10-Q Autolus Therapeutics For: Jun 30 | SEC filing · Form 10-Q | +1.28% | -9.40% | |
| Form 8-K Autolus Therapeutics For: Aug 11 | SEC filing · Form 8-K | +3.92% | +14.22% | |
| Form 8-K Autolus Therapeutics For: Aug 03 | SEC filing · Form 8-K | -5.23% | +5.81% | |
| Form 8-K Autolus Therapeutics For: Jul 30 | SEC filing · Form 8-K | -5.23% | +5.81% | |
| Form 8-K Autolus Therapeutics For: Jun 29 | SEC filing · Form 8-K | +0.30% | -2.44% | |
| Form 8-K Autolus Therapeutics For: Jun 05 | SEC filing · Form 8-K | +0.00% | -1.35% | |
| Form 10-Q Autolus Therapeutics For: Mar 31 | SEC filing · Form 10-Q | +0.63% | +3.17% | |
| Form 8-K Autolus Therapeutics For: May 14 | SEC filing · Form 8-K | -4.49% | +1.92% | |
| Form EFFECT Autolus Therapeutics | SEC filing · Form EFFECT | -2.07% | +0.59% | |
| Form 8-K Autolus Therapeutics For: Apr 29 | SEC filing · Form 8-K | +1.43% | +0.71% | |
| Form 8-K Autolus Therapeutics For: Apr 14 | SEC filing · Form 8-K | +1.86% | -0.62% | |
| Form DEL AM Autolus Therapeutics | SEC filing · Form DEL | -0.34% | +0.00% | |
| Form S-3 Autolus Therapeutics | SEC filing · Form S-3 | +1.71% | +0.69% | |
| Form 8-K Autolus Therapeutics For: Apr 08 | SEC filing · Form 8-K | -0.34% | -1.34% | |
| Form 10-K Autolus Therapeutics For: Dec 31 | SEC filing · Form 10-K | -2.85% | +3.25% | |
| Form 8-K Autolus Therapeutics For: Mar 27 | SEC filing · Form 8-K | -1.24% | +0.00% | |
| Form 8-K Autolus Therapeutics For: Jan 21 | SEC filing · Form 8-K | +2.88% | +2.16% | |
| Form 8-K Autolus Therapeutics For: Jan 12 | SEC filing · Form 8-K | -4.47% | -16.20% | |
| Form 8-K Autolus Therapeutics For: Dec 01 | SEC filing · Form 8-K | +1.87% | +10.45% | |
| Form S-8 Autolus Therapeutics | SEC filing · Form S-8 | +1.53% | -3.05% | |
| Form 10-Q Autolus Therapeutics For: Sep 30 | SEC filing · Form 10-Q | -4.07% | — | |
| Form 8-K Autolus Therapeutics For: Nov 12 | SEC filing · Form 8-K | +2.07% | +0.74% | |
| Form 10-Q Autolus Therapeutics For: Jun 30 | SEC filing · Form 10-Q | -1.63% | -14.42% | |
| Form 8-K Autolus Therapeutics For: Aug 12 | SEC filing · Form 8-K | +1.71% | — | |
| Form 8-K Autolus Therapeutics For: Jun 26 | SEC filing · Form 8-K | -0.37% | +0.87% | |
| Form 8-K Autolus Therapeutics For: Jun 02 | SEC filing · Form 8-K | +1.01% | +4.54% | |
| Form 8-K Autolus Therapeutics For: May 23 | SEC filing · Form 8-K | +0.84% | +7.30% | |
| Form EFFECT Autolus Therapeutics | SEC filing · Form EFFECT | +1.16% | +3.10% | |
| Form 10-Q Autolus Therapeutics For: Mar 31 | SEC filing · Form 10-Q | +4.07% | -2.22% | |
| Form 8-K Autolus Therapeutics For: May 08 | SEC filing · Form 8-K | -2.89% | -7.53% | |
| Form S-1 Autolus Therapeutics | SEC filing · Form S-1 | +4.07% | -2.22% | |
| Form 8-K Autolus Therapeutics For: Apr 23 | SEC filing · Form 8-K | +1.51% | -8.48% | |
| Form 8-K Autolus Therapeutics For: Feb 28 | SEC filing · Form 8-K | -1.02% | -9.52% | |
| Form EFFECT Autolus Therapeutics | SEC filing · Form EFFECT | -0.33% | +0.00% | |
| Form 10-K Autolus Therapeutics For: Dec 31 | SEC filing · Form 10-K | -5.23% | -1.16% | |
| Form 8-K Autolus Therapeutics For: Mar 20 | SEC filing · Form 8-K | -2.49% | -16.67% | |
| Form POS AM Autolus Therapeutics | SEC filing · Form POS | -5.23% | -1.16% | |
| Form POSASR Autolus Therapeutics | SEC filing · Form POSASR | -5.23% | -1.16% | |
| Form 8-K Autolus Therapeutics For: Jan 13 | SEC filing · Form 8-K | -2.17% | -0.43% | |
| Form S-8 Autolus Therapeutics | SEC filing · Form S-8 | -3.80% | -2.53% | |
| Form 10-Q Autolus Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +2.06% | -3.23% | |
| Form 8-K Autolus Therapeutics For: Nov 08 | SEC filing · Form 8-K | -2.68% | -10.48% | |
| Form 8-K Autolus Therapeutics For: Nov 12 | SEC filing · Form 8-K | -2.68% | -10.48% | |
| Form 8-K Autolus Therapeutics For: Sep 26 | SEC filing · Form 8-K | -0.85% | -0.85% | |
| Form 8-K Autolus Therapeutics For: Sep 13 | SEC filing · Form 8-K | -13.93% | -13.48% | |
| Form 8-K Autolus Therapeutics For: Sep 10 | SEC filing · Form 8-K | -0.25% | +2.00% | |
| Form 10-Q Autolus Therapeutics For: Jun 30 | SEC filing · Form 10-Q | -2.24% | -3.42% | |
| Form 8-K Autolus Therapeutics For: Aug 08 | SEC filing · Form 8-K | -5.05% | -12.50% | |
| Form 8-K Autolus Therapeutics For: Jun 28 | SEC filing · Form 8-K | +1.16% | +0.58% | |
| Form 8-K Autolus Therapeutics For: Jun 05 | SEC filing · Form 8-K | +0.70% | -0.47% | |
| Form 8-K Autolus Therapeutics For: May 31 | SEC filing · Form 8-K | -0.44% | -6.89% | |
| Form 10-Q Autolus Therapeutics For: Mar 31 | SEC filing · Form 10-Q | -1.60% | -8.01% | |
| Form 8-K Autolus Therapeutics For: May 17 | SEC filing · Form 8-K | +3.56% | -2.44% | |
| Form 8-K Autolus Therapeutics For: May 13 | SEC filing · Form 8-K | -2.28% | +1.52% | |
| Form NT 10-Q Autolus Therapeutics For: May 13 | SEC filing · Form NT | -1.07% | +2.30% | |
| Form 8-K Autolus Therapeutics For: Mar 26 | SEC filing · Form 8-K | -1.75% | -9.41% | |
| Form S-3ASR Autolus Therapeutics | SEC filing · Form S-3ASR | -1.75% | -9.41% | |
| Form 10-K Autolus Therapeutics For: Dec 31 | SEC filing · Form 10-K | +0.97% | +1.94% | |
| Form 8-K Autolus Therapeutics For: Mar 21 | SEC filing · Form 8-K | +0.97% | +1.94% | |
| Form 8-K/A Autolus Therapeutics For: Mar 14 | SEC filing · Form 8-K | +0.17% | +6.62% | |
| Form 8-K Autolus Therapeutics For: Mar 14 | SEC filing · Form 8-K | -3.60% | -8.73% | |
| Form D Autolus Therapeutics | SEC filing · Form D | +1.14% | +2.93% | |
| Form 8-K Autolus Therapeutics For: Feb 13 | SEC filing · Form 8-K | +0.28% | +3.42% | |
| Form 8-K Autolus Therapeutics For: Feb 06 | SEC filing · Form 8-K | -0.77% | -7.69% | |
| Form 8-K Autolus Therapeutics For: Feb 08 | SEC filing · Form 8-K | +0.55% | +5.63% | |
| Form S-3ASR Autolus Therapeutics | SEC filing · Form S-3ASR | -0.77% | -7.69% | |
| Form 8-K Autolus Therapeutics For: Jan 22 | SEC filing · Form 8-K | -0.43% | +2.59% | |
| Form 8-K Autolus Therapeutics For: Jan 09 | SEC filing · Form 8-K | +0.30% | +0.52% | |
| Form 8-K Autolus Therapeutics For: Dec 19 | SEC filing · Form 8-K | +0.26% | -0.35% | |
| Form 8-K Autolus Therapeutics For: Dec 09 | SEC filing · Form 8-K | -2.33% | +4.42% | |
| Form 8-K Autolus Therapeutics For: Nov 27 | SEC filing · Form 8-K | -0.65% | +3.02% | |
| Form 10-Q Autolus Therapeutics For: Sep 30 | SEC filing · Form 10-Q | -1.15% | -1.72% | |
| Form 8-K Autolus Therapeutics For: Nov 09 | SEC filing · Form 8-K | -1.32% | -7.92% | |
| Form S-8 Autolus Therapeutics | SEC filing · Form S-8 | -7.13% | -9.09% | |
| Form 6-K Autolus Therapeutics For: Sep 30 | SEC filing · Form 6-K | +9.32% | +27.02% |
Keep exploring
More AUTL: earnings → · analyst actions → · AUTL overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Akebia Therapeutics, Inc. (AKBA) | 377 | 0.00% | 49% |
| Amneal Pharmaceuticals, Inc. - Class A (AMRX) | 377 | -0.08% | 46% |
| Solid Biosciences Inc. (SLDB) | 375 | -0.17% | 46% |
| Halozyme Therapeutics, Inc. (HALO) | 374 | -0.11% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.